Carboplatin + Paclitaxel + Bevacizumab

2 trials

Sponsors

Shizuoka Cancer Center, Shizuoka Cancer Cetner

Conditions

Non-squamous non-small-cell lung cancer

Phase 2

Exploratory analysis of serum and pleural effusion biomarkers in patients with advanced Non-squamous non-small-cell lung cancer with large malignant pleural effusion

Active, not recruitingJPRN-UMIN000006768

Shizuoka Cancer CetnerNon-squamous non-small-cell lung cancer

Start: 2012-01-01Target: 32Updated: 2026-06-29

Phase II study of Carboplatin, Paclitaxel and Bevacizumab in patients with advanced Non-squamous non-small-cell lung cancer with large malignant pleural effusion.

Active, not recruitingJPRN-UMIN000006767

Shizuoka Cancer CenterNon-squamous non-small-cell lung cancer

Start: 2012-01-01Target: 32Updated: 2026-06-29